[HTML] jci.org

[HTML][HTML] Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa, D Prandi… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …
被引用次数：25 相关文章

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa… - Journal of Clinical …, 2021 - mayoclinic.elsevierpure.com
BACKGROUND. Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.

D Liu, MA Augello, I Grbesa, D Prandi, Y Liu… - Journal of Clinical …, 2021 - go.gale.com
BACKGROUND. Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa, D Prandi, Y Liu… - THE JOURNAL OF …, 2021 - iris.unitn.it
BACKGROUND. Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa, D Prandi… - Journal of Clinical …, 2021 - search.proquest.com
BACKGROUND. Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa, D Prandi… - Journal of Clinical …, 2021 - pure.johnshopkins.edu
BACKGROUND. Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa, D Prandi, Y Liu… - THE JOURNAL OF …, 2021 - cris.fbk.eu
BACKGROUND Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …
[PDF] researchgate.net

[PDF][PDF] Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa, D Prandi, Y Liu, JE Shoag… - 2021 - researchgate.net
BACKGROUND. Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …
[HTML] nih.gov

[HTML][HTML] Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa, D Prandi… - The Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Molecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

D Liu, MA Augello, I Grbesa… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDMolecular characterization of prostate cancer (PCa) has revealed distinct
subclasses based on underlying genomic alterations occurring early in the natural history of …